Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|May 29, 2014

Rockland Immunochemicals Expands Laboratories

Rockland Immunochemicals develops new laboratories in Limerick, PA.

Rockland Immunochemicals is expanding its laboratories to address an increasing demand for life-science research tools, building a 60,000-ft2 facility in Limerick, PA. The new facilities will include cleanrooms for cell culture, suites for molecular biology, larger lot capacity production capabilities, and increased aseptic processing areas. Rockland began planning for its new facility in 2012.


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.